tada, I certainly agree with your perspective.

I hope that your comment "I don't know but have an idea that the doctors running this current Zenith trial will have screened the patients to use the ones that have the best chance of success based on their genetic or epigenetic makeup." is true and the the quality control on this trial is extremely high. Remember, on the ASSURE trial there were quality control issues so let's hope the mCRPC trial of zen3694 is tightly managed.

I sure would like to hear some info regarding the zen3694 trial. The fact that they were able to make a significant hiring at Zenith suggests something positive.

I sure do hope to see some liquidity at a good price.

GLTA

Toinv